So the question is I'm sure for any newbies to MNKD is what to believe?
Posts and articles that make pointless comparisons and or tend to shy away from any positive possibilities? Those that only enhance the potentially negative?
OR the words spoken by those such as FROM SANOFI HEAD of U.S. PHARMACEUTICALS as below?? or MANNKINDS Billionaire Al Mann or THEIR CFO Matt Pfeffer??
I'm all for listening to both sides of a case as long as it not obviously written out of ignorance, ignoring the facts to favor one side. Are there risks here? You betcha. IMO opinion it's to early to tell and IF DTC gets people aware of Afrezza then the rewards will be worth the ups and downs we see now. Still speculative imo so invest what one could afford to loose in worst case scenario.
Quote;
"At this early stage, MannKind and Sanofi have obviously not declared Afrezza a failure. In fact, in a recent exclusive interview with BioPharma Dive, Sanofi's head of U.S. pharmaceuticals told us that Afrezza was off to a "solid start" despite the numbers.
"The strategy here is targeted and focused, and that's important because we need to educate the specialists and high-prescribing physicians for appropriate usage of their medicine," said Jez Moulding. "In terms of access, we've secured third-tier benefit in a number of plans. We'll be launching print and direct-to-consumer promotion in the next few weeks, and we'll be launching a 12-unit cartridge later in Q3."
Btw
I Currently hold no position in MNKD OR SNY.
